Nuveen Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-549,293
| Closed | -$32.4M | – | 3501 |
|
|
2022
Q1 | $32.4M | Buy |
549,293
+188,405
| +52% | +$11.1M | 0.01% | 877 |
|
|
2021
Q4 | $21.3M | Buy |
360,888
+51,495
| +17% | +$3.04M | 0.01% | 1196 |
|
|
2021
Q3 | $18.3M | Buy |
309,393
+3,523
| +1% | +$208K | 0.01% | 1328 |
|
|
2021
Q2 | $18M | Sell |
305,870
-103,735
| -25% | -$6.12M | 0.01% | 1449 |
|
|
2021
Q1 | $24.2M | Buy |
409,605
+11,323
| +3% | +$668K | 0.01% | 1181 |
|
|
2020
Q4 | $23.5M | Buy |
398,282
+4,425
| +1% | +$261K | 0.01% | 1146 |
|
|
2020
Q3 | $23.2M | Buy |
393,857
+41,125
| +12% | +$2.43M | 0.01% | 969 |
|
|
2020
Q2 | $20.8M | Buy |
352,732
+4,824
| +1% | +$285K | 0.01% | 1021 |
|
|
2020
Q1 | $2.21M | Buy |
347,908
+8,459
| +2% | +$53.8K | ﹤0.01% | 2138 |
|
|
2019
Q4 | $3.54M | Sell |
339,449
-75,298
| -18% | -$785K | ﹤0.01% | 2165 |
|
|
2019
Q3 | $1.63M | Buy |
414,747
+44,037
| +12% | +$173K | ﹤0.01% | 2493 |
|
|
2019
Q2 | $5.51M | Buy |
+370,710
| New | +$5.51M | ﹤0.01% | 1932 |
|
|
2018
Q1 | – | Sell |
-12,265
| Closed | -$834K | – | 1141 |
|
|
2017
Q4 | $834K | Sell |
12,265
-65
| -0.5% | -$4.42K | 0.01% | 794 |
|
|
2017
Q3 | $1.02M | Buy |
12,330
+5,130
| +71% | +$423K | 0.01% | 759 |
|
|
2017
Q2 | $674K | Buy |
+7,200
| New | +$674K | ﹤0.01% | 848 |
|
|
2015
Q3 | – | Sell |
-18,314
| Closed | -$1.61K | – | 1518 |
|
|
2015
Q2 | $1.61K | Buy |
18,314
+1,354
| +8% | +$119 | 0.01% | 914 |
|
|
2015
Q1 | $1.26M | Buy |
16,960
+4,891
| +41% | +$363K | 0.01% | 1029 |
|
|
2014
Q4 | $676K | Buy |
+12,069
| New | +$676K | ﹤0.01% | 1239 |
|